BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2021 7:48:08 AM | Browse: 541 | Download: 958
 |
Received |
|
2021-04-17 10:56 |
|
Peer-Review Started |
|
2021-04-17 10:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-03 19:12 |
|
Revised |
|
2021-06-30 07:54 |
|
Second Decision |
|
2021-08-13 02:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-13 08:05 |
|
Articles in Press |
|
2021-08-13 08:05 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-24 04:15 |
|
Typeset the Manuscript |
|
2021-09-18 01:23 |
|
Publish the Manuscript Online |
|
2021-09-23 07:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Treatment of hepatitis B virus infection in children and adolescents
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mariangela Stinco, Chiara Rubino, Sandra Trapani and Giuseppe Indolfi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giuseppe Indolfi, MD, Professor, Department Neurofarba, University of Florence and Meyer Children’s University Hospital, 6 Gaetano Pieraccini, Florence 50139, Italy. giuseppe.indolfi@meyer.it |
| Key Words |
Hepatitis B; Children; Adolescents; Antiviral therapy; Tenofovir disoproxil fumarate; Entecavir; Interferon |
| Core Tip |
Hepatitis B virus (HBV) is a major cause of acute and chronic liver disease. During childhood asymptomatic chronic hepatitis B is the most common outcome of the infection and a conservative approach is usually recommended. In selected patients there is a strict indication for treatment. Different drugs have been approved by United States Food and Drug Administration and European Medicines Agency for treatment of children and adolescents with chronic HBV infection. The main goal of the treatment is to reduce the risk of progression to cirrhosis and hepatocellular carcinoma through the suppression of HBV replication. |
| Publish Date |
2021-09-23 07:48 |
| Citation |
Stinco M, Rubino C, Trapani S, Indolfi G. Treatment of hepatitis B virus infection in children and adolescents. World J Gastroenterol 2021; 27(36): 6053-6063 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i36/6053.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i36.6053 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
